Biotech

All Articles

Gene editor Volume laying off 131 employees

.Merely days after gene publisher Volume Biosciences revealed hidden working slices, a more clear pi...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is actually laying off a fourth of its own staff as the oncology biotech downsize its ...

J &amp J apply for FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken one more step towards recognizing a profit on its own $6.5 ...

Gain's period 1 succeed paves method to verify Parkinson's medication's worth

.Gain Therapeutics has actually established its sights on verifying the effectiveness of its Parkins...

Actinogen documents brand-new phase 2 data to restore anxiety medication

.Actinogen Medical's hopes-- and inventory rate-- have recoiled a little coming from previously this...

Pfizer as well as Flagship incorporate Quotient to multibillion-dollar formula

.Crown Jewel Pioneering and also Pfizer have actually included Quotient right into their 10-program ...

Bayer markers $547M contract to push boundaries of noncoding RNA

.Bayer managers were actually eager to worry to Strong this summer season that the German pharma tit...

UK introduces plans to release 18 new clinical trial hubs

.Among a yearslong clinical test decrease in the U.K., a brand-new public-private collaboration has ...

UPDATE: Genentech telegrams 93 layoffs in The golden state after discussing strategies to shutter cancer cells immunology investigation system

.Observing the statement of a big cutback shot in April as well as a primary rebuilding effort intro...

Neurocrine's KarXT opponent reaches in phase 2-- however merely at reduced dose

.Neurocrine Biosciences has obtained its own hoped-for profile in a period 2 mental illness test, de...